Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TGM2 | P21980 | 2/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3366797 | 0.90 | MAPK1 (0.41) | MAPK1HIF1AZDHHC20ZDHHC2RAB9A | |
| SCHEMBL12301857 | 0.88 | ZDHHC20 (0.52) | MAPK1HIF1AZDHHC20ZDHHC2RAB9A | |
| SCHEMBL18912608 | 0.85 | MAPK1 (0.49) | MAPK1HIF1AZDHHC20ZDHHC2RAB9A | |
| SCHEMBL18231989 | 0.83 | MAPK1 (0.48) | MAPK1HIF1AZDHHC20ZDHHC2RAB9A | |
| SCHEMBL18359027 | 0.82 | ZDHHC20 (0.50) | MAPK1HIF1AZDHHC20ZDHHC2RAB9A | |
| SCHEMBL610613 | 0.81 | MAPK1 (0.68) | MAPK1HIF1ARAB9ASMN1; SMN2GAA | |
| SCHEMBL19955013 | 0.79 | MAPK1 (0.44) | MAPK1HIF1AZDHHC20ZDHHC2RAB9A | |
| SCHEMBL15651389 | 0.78 | GAA (0.49) | MAPK1HIF1ARAB9ASMN1; SMN2TP53 | |
| SCHEMBL28722817 | 0.77 | SIGMAR1 (0.47) | MAPK1HIF1AZDHHC20ZDHHC2RAB9A | |
| SCHEMBL10714041 | 0.76 | MAPK1 (0.62) | MAPK1HIF1AZDHHC20ZDHHC2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170152362-A1 | FUNCTIONAL POLYMER MEMBRANE, STACK OR DEVICE PROVIDED WITH FUNCTIONAL POLYMER MEMBRANE, AND METHOD OF PRODUCING FUNCTIONAL POLYMER MEMBRANE | FUJIFILM CORPORATION (JP) | 2017-06-01 | — | — | US | disclosed |
| US-20160334364-A1 | GEL FOR USE IN POLYACRYLAMIDE GEL ELECTROPHORESIS AND ELECTROPHORESIS DEVICE USING SAID GEL | SHARP KABUSHIKI KAISHA (JP) | 2016-11-17 | — | — | US | disclosed |
| US-9359461-B2 | Ethylene copolymers, compositions comprising same and preparation and treatment methods | L'OREAL (FR) | 2016-06-07 | — | — | US | disclosed |
| US-9359461-B2 | Ethylene copolymers, compositions comprising same and preparation and treatment methods | L'OREAL (FR) | 2016-06-07 | — | — | US | disclosed |
| US-8753615-B2 | Ethylene copolymer with PEG, cationic and anionic units, cosmetic composition including same and treatment method | L'OREAL (FR) | 2014-06-17 | — | — | US | disclosed |
| WO-2012175330-A2 | COSMETIC USE OF A FLOCCULANT POLYMER AS ANTIPERSPIRANT | L'OREAL (FR) | 2012-12-27 | — | — | WO | disclosed |
| EP-1765893-B1 | NOVEL ETHYLENE COPOLYMERS, COMPOSITIONS COMPRISING SAME AND PREPARATION AND TREATMENT METHODS | OREAL (FR) | 2012-08-22 | — | — | EP | disclosed |
| EP-2124869-B1 | POLYMER PARTICLE DISPERSION, COMPOSITION CONTAINING THE SAME AND COSMETIC TREATMENT METHOD | OREAL (FR) | 2012-08-15 | — | — | EP | disclosed |
| US-8178079-B2 | Ethylene copolymers, compositions containing said copolymers and treatment method | L'OREAL S.A. (FR) | 2012-05-15 | — | — | US | disclosed |
| US-8178079-B2 | Ethylene copolymers, compositions containing said copolymers and treatment method | L'OREAL S.A. (FR) | 2012-05-15 | — | — | US | disclosed |
| US-20080311066-A1 | Cosmetics Compositions Comprising at Least One Surfactant and at Least One Novel Ethylene Copolymer with Polyethylene Glycol Grafts | L'ORÉAL (FR) | 2008-12-18 | — | — | US | disclosed |
| US-20080292577-A1 | Novel Ethylene Copolymers, Compositions Comprising Same and Preparation and Treatment Methods | L'OREAL (FR) | 2008-11-27 | — | — | US | disclosed |
| US-20080292577-A1 | Novel Ethylene Copolymers, Compositions Comprising Same and Preparation and Treatment Methods | L'OREAL (FR) | 2008-11-27 | — | — | US | disclosed |
| US-20080286218-A1 | Cosmetic Compositions Containing at Least One Conditioning Agent and at Least One Ethylene Polymer with Polyethylene Glycol Grafts | L'OREAL S.A. (FR) | 2008-11-20 | — | — | US | disclosed |
| US-20080286218-A1 | Cosmetic Compositions Containing at Least One Conditioning Agent and at Least One Ethylene Polymer with Polyethylene Glycol Grafts | L'OREAL S.A. (FR) | 2008-11-20 | — | — | US | disclosed |
| WO-2008104698-A2 | POLYMER PARTICLE DISPERSION, COMPOSITION CONTAINING THE SAME AND COSMETIC TREATMENT METHOD | L'OREAL (FR) | 2008-09-04 | — | — | WO | disclosed |
| US-20080161324-A1 | Compositions and methods for treatment of viral diseases | EXCRX (SINGAPORE) PTE. LTD. (F.K.A. COMBINATORX (SINGAPORE) PTE LTD.) (SG) | 2008-07-03 | — | — | US | disclosed |
| WO-2008033466-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | COMBINATORX (SINGAPORE) PRE. LTD. (SG) | 2008-03-20 | — | — | WO | disclosed |
| US-20080014154-A1 | Novel Ethylene Copolymers, Compositions Containing Said Copolymers and Treatment Method | L'OREAL S.A. (FR) | 2008-01-17 | — | — | US | disclosed |
| US-20080014154-A1 | Novel Ethylene Copolymers, Compositions Containing Said Copolymers and Treatment Method | L'OREAL S.A. (FR) | 2008-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311066-A1 | Cosmetics Compositions Comprising at Least One Surfactant and at Least One Novel Ethylene Copolymer with Polyethylene Glycol Grafts | ACMSD, ERCC1, ASS1 | MAPK1 2325/4885HIF1A 1820/4885ZDHHC20 750/4885 |
| US-20080292577-A1 | Novel Ethylene Copolymers, Compositions Comprising Same and Preparation and Treatment Methods | ETV6, ASIC1, NOTUM | MAPK1 2219/4885HIF1A 1203/4885ZDHHC20 2294/4885 |
| US-20080286218-A1 | Cosmetic Compositions Containing at Least One Conditioning Agent and at Least One Ethylene Polymer with Polyethylene Glycol Grafts | SGMS2, SGMS1, SMS | MAPK1 1815/4885HIF1A 2588/4885ZDHHC20 224/4885 |
| US-20080161324-A1 | Compositions and methods for treatment of viral diseases | HAVCR2, EIF2AK2, RNASE1 | MAPK1 4544/4885HIF1A 568/4885ZDHHC20 832/4885 |
| US-20080014154-A1 | Novel Ethylene Copolymers, Compositions Containing Said Copolymers and Treatment Method | MMAB, SGMS2, SGMS1 | MAPK1 4011/4885HIF1A 1314/4885ZDHHC20 567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.